{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:20Z","timestamp":1786654100550,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118229","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:37:29Z","timestamp":1783665449000},"page":"118229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NAT10 drives chemoresistance in AML through ac4C-dependent stabilization of PLEKHA4"],"prefix":"10.1016","volume":"252","author":[{"given":"Qi","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoneng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Like","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118229_b0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"issue":"22","key":"10.1016\/j.bcp.2026.118229_b0010","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.3390\/ijms21228505","article-title":"Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia","volume":"21","author":"Gurnari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2026.118229_b0015","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0020","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41467-025-58370-9","article-title":"Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance","volume":"16","author":"Takao","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/foac025","article-title":"Post-transcriptional regulation during stress","volume":"22","author":"Hern\u00e1ndez-Elvira","year":"2022","journal-title":"FEMS Yeast Res."},{"issue":"23","key":"10.1016\/j.bcp.2026.118229_b0030","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1016\/j.molcel.2025.11.004","article-title":"Timing of transcription controls the selective translation of newly synthesized mRNAs during acute environmental stress","volume":"85","author":"Zedan","year":"2025","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"issue":"7683","key":"10.1016\/j.bcp.2026.118229_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.118229_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 Inhibits Hematopoietic Stem\/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m(6)A Modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7860","key":"10.1016\/j.bcp.2026.118229_b0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.trecan.2025.10.002","article-title":"Functional plasticity of RNA-binding proteins in cancer: both friend and foe","volume":"12","author":"Harrison-Oakes","year":"2026","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2026.118229_b0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/leu.2015.253","article-title":"Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia","volume":"30","author":"Chiu","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.118229_b0065","doi-asserted-by":"crossref","unstructured":"Y. Shi, J. Sun, H. Chen, K. Yu, J. Li, B. Liu, RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms, iScience 29(3) (2026) 115080.","DOI":"10.1016\/j.isci.2026.115080"},{"issue":"16","key":"10.1016\/j.bcp.2026.118229_b0070","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1093\/nar\/gkad628","article-title":"NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells","volume":"51","author":"Liu","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118229_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf504","article-title":"Nat10 maintains the homeostasis of pluripotent and 2-cell-like states in mouse embryonic stem cells through mRNA cytidine acetylation","volume":"53","author":"Feng","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118229_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13577","article-title":"NAT10-mediated ac(4)C modification promotes ectoderm differentiation of human embryonic stem cells via acetylating NR2F1 mRNA","volume":"57","author":"Ge","year":"2024","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.bcp.2026.118229_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady0301","article-title":"Nat10-mediated ac4C epitranscriptomics orchestrates hematopoietic stem\/progenitor cell fate determination via translation control","volume":"12","author":"Huang","year":"2026","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.bcp.2026.118229_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","article-title":"Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner","volume":"33","author":"Liao","year":"2023","journal-title":"Cell Res."},{"issue":"32","key":"10.1016\/j.bcp.2026.118229_b0095","article-title":"NAT10\/ac4C\/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv Sci (weinh)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41420-026-03107-w","article-title":"NAT10 promotes cisplatin resistance and immune escape by increasing the expression of DUSP1 and PD-L1 in gastric cancer","volume":"12","author":"Qian","year":"2026","journal-title":"Cell Death Discov"},{"issue":"9","key":"10.1016\/j.bcp.2026.118229_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30330","article-title":"NAT10-mediated ac(4)C modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.bcp.2026.118229_b0110","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","article-title":"NAT10-mediated mRNA N(4)-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia","volume":"26","author":"Zhang","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41389-025-00559-0","article-title":"PLEKHA4 is transcriptionally regulated by HOXD9 and regulates glycolytic reprogramming and progression in glioblastoma via activation of the STAT3\/SOCS-1 pathway","volume":"14","author":"Zhang","year":"2025","journal-title":"Oncogenesis"},{"issue":"8","key":"10.1016\/j.bcp.2026.118229_b0120","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/0008-5472.CAN-20-2584","article-title":"PLEKHA4 Promotes Wnt\/\u03b2-Catenin Signaling-Mediated G(1)-S transition and Proliferation in Melanoma","volume":"81","author":"Shami Shah","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118229_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4504474","article-title":"PLEKHA4 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma","volume":"2023","author":"Zhang","year":"2023","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0130","doi-asserted-by":"crossref","first-page":"11112","DOI":"10.1038\/s41598-019-47594-7","article-title":"PACES: prediction of N4-acetylcytidine (ac4C) modification sites in mRNA","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118229_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217159","article-title":"RNA ac(4)C modification in cancer: Unraveling multifaceted roles and promising therapeutic horizons","volume":"601","author":"Ouyang","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bcp.2026.118229_b0140","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.celrep.2019.04.060","article-title":"PLEKHA4\/kramer Attenuates Dishevelled Ubiquitination to Modulate Wnt and Planar Cell Polarity Signaling","volume":"27","author":"Shami Shah","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41419-025-08328-y","article-title":"NAT10-mediated N4-acetylcytidine (ac4C) modification of PIK3R2 mRNA promotes malignant progression of glioblastoma","volume":"17","author":"Meng","year":"2025","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","article-title":"Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma","volume":"9","author":"Pan","year":"2023","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41419-026-08568-6","article-title":"NAT10-mediated ac4C RNA acetylation stabilizes CXCL5\/DEK mRNA to drive proliferation and metastasis in lung adenocarcinoma","volume":"17","author":"Hu","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118229_b0160","doi-asserted-by":"crossref","unstructured":"H. Li, H. Wu, S. Li, Q. Wang, G. Li, X. Ma, Y. Gong, Y. Chu, S. Jin, X. Chen, X. Zhang, D. Pang, Mechanistic study of N-acetyltransferase 10 deficiency enhancing olaparib sensitivity in triple negative breast cancer by inhibiting RAD51 N4-acetylcytidine modification, iScience 28(7) (2025) 112860.","DOI":"10.1016\/j.isci.2025.112860"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118229_b0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10495-021-01704-x","article-title":"WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme","volume":"27","author":"Ma","year":"2022","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.bcp.2026.118229_b0170","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202254895","article-title":"Noncanonical Wnt signaling promotes colon tumor growth, chemoresistance and tumor fibroblast activation","volume":"24","author":"Fuertes","year":"2023","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.bcp.2026.118229_b0175","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20194334","article-title":"TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt\/\u03b2-catenin signaling","volume":"40","author":"Xiao","year":"2020","journal-title":"Biosci. Rep."},{"issue":"22","key":"10.1016\/j.bcp.2026.118229_b0180","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1209346","article-title":"A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia","volume":"25","author":"De Toni","year":"2006","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.bcp.2026.118229_b0185","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/sj.leu.2404732","article-title":"The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia","volume":"21","author":"Mikesch","year":"2007","journal-title":"Leukemia"},{"issue":"28","key":"10.1016\/j.bcp.2026.118229_b0190","doi-asserted-by":"crossref","first-page":"16690","DOI":"10.1073\/pnas.1910547117","article-title":"Single-molecule dynamics of Dishevelled at the plasma membrane and Wnt pathway activation","volume":"117","author":"Ma","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.bcp.2026.118229_b0195","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1042\/BCJ20170712","article-title":"The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance","volume":"475","author":"Hekmatshoar","year":"2018","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2026.118229_b0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1479-5876-11-94","article-title":"Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance","volume":"11","author":"Pasquier","year":"2013","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0205","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1038\/s41598-018-27649-x","article-title":"Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer","volume":"8","author":"Desir","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118229_b0210","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2024-200028","article-title":"M2-like Macrophages transfer Mitochondria to Acute Myeloid Leukaemia Cells Via Tunnelling Nanotubes Promoting Therapy Resistance","volume":"144","author":"Nwarunma","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2026.118229_b0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40364-023-00529-x","article-title":"Mitochondrial transfer in hematological malignancies","volume":"11","author":"Guo","year":"2023","journal-title":"Biomark Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600568X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600568X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:23:09Z","timestamp":1786652589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600568X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S000629522600568X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118229","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAT10 drives chemoresistance in AML through ac4C-dependent stabilization of PLEKHA4","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118229"}}